Evaluation of safety and efficacy of perioperative administration of TJ-100 in patients with postoperative functional aberration of the gastrointestinal tract due to surgery for colon cancer
Not Applicable
- Conditions
- colon cancer
- Registration Number
- JPRN-UMIN000032697
- Lead Sponsor
- Sapporo Medical University
- Brief Summary
Not available
- Detailed Description
Not available
Recruitment & Eligibility
- Status
- Complete: follow-up complete
- Sex
- All
- Target Recruitment
- 200
Inclusion Criteria
Not provided
Exclusion Criteria
1.Patients taking other Kampo medicines 2.Patients were pregnant, possibly pregnant or considering pregnancy 3.Patients with serious ischemic heart disease 4.Patients with cirrhosis or active hepatitis 5.Patients with dyspnea requiring oxygen administration 6.Patients under dialysis due to chronic renal failure 7.Patients requiring combined resection of any other organ 8.Patients ineligible for the study for any other reason, as judged by the investigator
Study & Design
- Study Type
- Interventional
- Study Design
- Not specified
- Primary Outcome Measures
Name Time Method the time until first flatus following colon surgery
- Secondary Outcome Measures
Name Time Method 1.The time until first defecation following colon surgery 2.CRP, WBC, neutrophil of POD 1,3 3.The maximumu of body temperature 4.Hospital stay after colorectal surgery 5.Postoperative complication 6.Adverse events